Although PLG’s pharmacological profile suggested that this compound would have potential in treating neurological diseases such as Parkinson’s disease and tardive dyskinesia, the peptide nature of PLG limits its potential as a drug [10–11]. Here, PLG is linked to nervous system disorder.